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Summary
Objective: Runx2 (also known as Cbfa1) is a transcription factor required for chondrocyte maturation and osteoblast differentiation. While
there is information on the regulation of its expression during osteogenesis, much less is known about it during cartilage maturation. Here
we asked whether Runx2 expression and function are affected by retinoic acid (RA) and parathyroid hormone-related peptide (PTHrP), which
represent an important stimulator and inhibitor of chondrocyte maturation, respectively.
Design: We first cloned and characterized Runx2 expressed by chick chondrocytes (cRunx2). We then constructed expression vectors of
cRunx2 and a dominant-negative form (DN-cRunx2) and determined their effects on chondrocyte maturation in culture before and during
retinoid and PTHrP treatment.
Results: cRunx2 showed similar transactivation activity to that of its mammalian counterparts although it has a very short QA domain and
lacks a small portion of the PST domain. cRunx2 over-expression stimulated chondrocyte maturation, as indicated by increases in alkaline
phosphatase activity (APase), mineralization, and type X collagen and MMP-13 expression, and by maintenance of Indian hedgehog (Ihh)
expression. RA treatment stimulated cRunx2 gene expression and boosted its pro-maturation effects. PTHrP treatment blocked Runx2
expression and its pro-maturation effects. Over-expression of DN-cRunx2 inhibited maturation and even prevented RA from exerting its
pro-maturation role.
Conclusions: As previously indicated by mammalian studies, cRunx2 has chondrocyte pro-maturation activity. Its expression and roles are
favorably modulated by retinoid signaling but are completely inhibited by PTHrP. A model integrating cRunx2 with PTHrP, Ihh and retinoid
signaling and operating during skeletogenesis is proposed. © 2003 OsteoArthritis Research Society International. Published by Elsevier
Science Ltd. All rights reserved.
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The process of endochondral ossification plays a major role
in skeletogenesis. This process consists of cartilage for-
mation and replacement of cartilage by bone1,2. Cartilagi-
nous rudiments first form at the appropriate sites and times
in the developing embryo. The chondrocytes then undergo
a series of maturation events. The cells actively proliferate
and synthesize a large amount of extracellular matrix
components, including aggrecan, type IX collagen and type
II collagen. They advance to the hypertrophic stage, which
is characterized by expression of type X collagen and high
activity of alkaline phosphatase (APase). The mature6hypertrophic cells finally induce matrix calcification, and the
resulting calcified hypertrophic cartilage is invaded by
blood vessels and replaced by endochondral bone.
These stereotypic and crucial steps in the endochondral
ossification process are strictly controlled since they have
to occur in precise spatio-temporal patterns during skel-
etogenesis. It is not surprising that several transcription
factors are found to participate in this regulation3. Runx2,
known also as Cbfa1, OSF2 or til1, is a member of the runt
transcription factor family1. This molecule is known as
an essential transcription factor for osteoblast differen-
tiation5,6. Recently, we demonstrated that Runx2 is also
involved in chondrocyte maturation7,8. Inactivation of
Runx2 function specific in chondrocytes results in severe
inhibition of chondrocyte maturation and retardation of
endochondral ossification8,9. Conversely, over-expression
of Runx2 in chondrocytes causes precocious induction of
chondrocyte maturation and endochondral bone for-
mation7,8,10. These data suggest that appropriate levels of
expression of Runx2 in chondrocytes are very importantReceived 28 May 2002; revision accepted 6 September 2002.
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Osteoarthritis and Cartilage, Vol. 11, No. 1 7for normal skeletal development. However, very little is
currently known about the mechanisms restricting Runx2
gene expression in skeletal cells and those modulating it.
This issue is not only of obvious importance for normal
skeletogenesis, but is relevant also to pathological skeletal
conditions, including osteoarthritis (OA). It is fairly well
established now that articular chondrocytes, cells, which
normally have a permanent phenotype and never undergo
maturation, can actually do so under pathological or exper-
imental conditions. Articular chondrocytes in culture and
osteoarthritic chondrocytes are found to express a number
of traits characteristic of growth plate maturing chondro-
cytes, including large cell size, high alkaline phosphatase
activity, and type X collagen11,12. It is conceivable that such
abnormal onset and progression of maturation in articular
chondrocytes may be accompanied by, and dependent on,
onset of Runx2 expression. Thus, it is of great importance
to understand what regulates Runx2 gene expression in
both normal and abnormal skeletal conditions.
In previous studies from our laboratories, we showed
that retinoid signaling strongly stimulates chondrocyte
maturation in culture13–15, while parathyroid hormone
(PTH) and parathyroid hormone-related peptide (PTHrP)
inhibits it16–18. We and others also showed that these
molecules play crucial roles in regulation of chick cartilage
development and skeletogenesis in vivo19–22. The present
study was carried out first to clone Runx2 expressed by
chick chondrocytes and then to compare it structurally and
functionally with its mammalian counterparts. We then
determined whether retinoid signaling and PTHrP regulate
and modulate Runx2 expression and action in chick
chondrocytes.Materials and methods
CLONING OF CHICK RUNX2
A library of adaptor-ligated double strand cDNAs was
made with poly A+ RNA isolated from 16-day-old chick
embryo tibia, using the Marathon cDNA amplification kit
according to the manufacturer’s protocol (Clontech, Palo
Alto, CA). The library was used as a template cDNA for 3′-
and 5′-RACE reactions. We first performed 3′-RACE reac-
tion with adaptor primer (AP1) included in the kit and with a
gene specific primer designed from consensus sequences
of mouse and human Runx2 (5′-TCA GTG ATT TAG GGC
GCA TTC CTC ATC C-3′). A single DNA fragment was
amplified by 3′-RACE reaction. The DNA band was
excised, purified by Qiaex II gel extraction kit (Roche
Diagnostic Inc., Tokyo, Japan) and subjected to direct
sequencing. After sequencing of the amplified product, we
designed a gene specific primer for 5′-RACE reaction
within the 3′-RACE product and used it to perform
5′-RACE. The sequence of gene specific primer used for
5′-RACE was 5′-GCA CGT CGG TGA TGG CTG GAA GTC
C-3′. The full length cDNA sequence was obtained by
assembling the sequences of the 3′-RACE and 5′-RACE
products. The sequence was verified by direct amplification
of whole cDNA sequences by PCR, using a primer pair
from the 5′- and 3′ ends of extended cDNA sequence and
the double strand cDNA library as a template. Accession
number of chick Runx-2 is AF450085.GCA TCA AAC AGC CTC TTC AGC-3′ and 5′-GGA TCC
CTC AGT ACG GCC TCC AAA CGG ACT-3′. By this
amplification step, BamHI sites at both ends and Kozak
consensus sequence were added to the full coding
sequence of cRunx2. The resulting DNA fragment was
subcloned into pGEM-T vector (Promega Co., Madison,
WI) by T-A cloning in a T7-5′-insert-3′-SP6 orientation
(pGEM-T-cRunx). This plasmid was used to prepare RNA
and DNA probes and as a source of full length coding
sequence for other plasmid constructions.
To construct a dominant negative form of cRunx2
(DN-cRunx2), a synthetic oligomer, 5′-AGC TTG ATA TCG
GGC CCC ATG GTG AAC AAA AAC TCA TCT CAG AAG
AGG ATC TGG ACT ACA AGG ACG ACG ATG ACA AGT
AGT AAA TCG ATA-3′ and 5′-CTA GTA TCG ATT TAC TAC
TTG TCA TCG TCG TCC TTG TAG TCC AGA TCC TCT
TCT GAG ATG AGT TTT TGT TCA CCA TGG GGC CCG
ATA TCA-3′ was synthesized, annealed, phosphorylated
and then sublconed into Hind III/Spe I- digested pGEM-T-
cRunx (pGEM-T-DN-cRunx2). Thus DN-cRunx2 encodes
AA1-207 of cRunx2 and myc and FLAG tags at the
C-terminus (EQKLISEE and DLDYKDDDDK). Full length
coding sequences of cRunx2 and DN-cRunx2 were also
subcloned into the Bam HI site of pSG5 expression vector
(Stratagene, La Jolla, CA) and designated pSG5-cRunx2
and pSG5-DN-cRunx2. These plasmids were used for
reporter gene assay experiments.RECOMBINANT VIRUS CONSTRUCTION
To facilitate construction of recombinant retrovirus
vectors, we inserted a polylinker into the Cla I site of
RCASBP(B) vector23. Briefly, oligonucleotides 5′-CGA TGC
ATC ACG TGA CTA GTT CGA AG C GGC CGC-3′ and
5′-CGG CGG CCG CTT CGA ACT AGT CAC GTG ATG
CAT-3′ were annealed, phosphorylated and ligated into Cla
I-digested RCASBP vectors. The resulting modified vectors
were designated RCASBP(B)L-14 and RCASBP(B)L-44.
RCASBP(B)L-14 has unique restriction sites in order of Cla
I, Nsi I, Spe I and Not I. RCASBP(B)L-44 has the same
restriction sites in a reverse orientation.
The entire coding sequence of cRunx2 was obtained
by digesting pGEM-T-cRunx2 with Bam HI and subcloned
into Bam HI site of pBluescript SK+ (Stratagene). cRunx2
insert was then prepared by digestion of the above
pBluescript SK+ with Spe I and Cla I and subcloned into
RCASBP(B)L-44 vector (RCAS-cRunx2). DN-cRunx2 frag-
ment was prepared from pGEM-T-DN-cRunx2 and sub-
cloned into BamHI and Hind III sites of pBluescript SK+.
DN-cRunx2 was then released from pBluescript SK+ by
digesting with Spe I and Cla I, and transferred into the
same restriction sites of RCASBP(B) (RCAS-DN-cRunx2).CELL CULTURES AND VIRUS INFECTION
Chicken embryo fibroblasts were obtained from the torso
of virus-free white leghorn 11-day-old embryos (line M;
Nisseiken, Yamanashi, Japan) and cultured in medium 199
containing 10% fetal bovine serum (FBS). Fibroblasts were
transfected with retroviral plasmid vectors by use of
FuGENE6 transfection reagent according to the manufac-
turer’s protocol (Roche Diagnostic Inc). Recombinant viral
particles present in the medium were concentrated by
ultracentrifugation (25 000 rpm for 3 h) and used to infect
freshly isolated chondrocytes24. Insert-less control viral
particles were produced and isolated in the same manner.PLASMID CONSTRUCTION
The entire coding sequence of cRunx2 was generated
by PCR with the following primers: 5′-GGA TCC ACC ATG
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from the caudal portion of Day 17 chick embryo sterna
sternum (line M) and cultured in high-glucose DMEM
containing 10% FBS11. Second-passage monolayer cul-
tures were allowed to become semiconfluent by growth for
5 to 7 days. When indicated, cultures were treated during
this period with 10 nM all-trans-retinoic acid (RA) (Sigma)
or 100 nM human PTHrp(1-34) (PTHrP) (Peptide Institute,
Osaka, Japan). By using immunoblotting analysis, we con-
firmed that these reagents did not significantly affect the
expression of virally introduced cRunx2 and DN-cRunx2
(not shown). To allow matrix mineralization, cultures were
provided with 1 mM -glycerophosphate14 and grown for
an additional 7 days. DNA, GAG and mineral contents were
determined as described24. APase activity associated with
the cell layer was revealed using p-nitrophenyl phosphate
(pNP) as a substrate15. Nuclear extracts were prepared
from control and virus-infected cultures according to
methods previously described25. Ten g of nuclear extract
was separated on 10.0% gels by SDS-PAGE and trans-
ferred to PVDF membranes (Millipore Japan, Tokyo,
Japan). Membranes were blocked with 10% horse serum
overnight at 22°C, incubated with 1:200 dilution of mono-
specific cRunx2 rabbit antibodies, rinsed and processed
with peroxidase-conjugated antirabbit IgG goat antibodies
and color development (Biomedical Technologies Inc.,
Stoughton, MA).
To analyse effects of RA and PTHrP on cRunx2 gene
expression, freshly isolated lower sternal chondrocytes
were plated on type I collagen-coated dishes at the initial
high density of 5×106 cells/well in 6-well plates and main-
tained in DMEM containing 10% FCS and 10 g/ml of
ascorbic acid. On day 3 of primary culture, cells were
treated with 10 nM RA or 100 mM PTHrP for 4 days. Total
RNAs were isolated on day 7 and subjected to RT-PCR
analysis.OSE REPORTER ASSAY
Transactivation activities of cRunx2 and DN-cRunx2
were examined after plasmid transfection and co-
transfection in second-passage immature chondrocyte
cultures (see below), using Runx2 target gene reporter
plasmid (p6xOSE2-Luc) as described previously8.PRODUCTION OF CHICK RUNX2 ANTIBODIES
The synthetic peptide TPCQQNFFWDPSTSR corre-
sponding to amino acids 11–25 at the N-terminal region of
chick Runx2 was selected based on strong predicted
antigenicity. Peptide was purified by HPLC, coupled to
maleimide-activated KLH (Pierce Biotechnology, Inc.,
Rockford, IL) at ratio of 1 mg peptide/mg KLH, and injected
into rabbits (Cocalico Biologicals Co., Denver, PA). Whole
antisera obtained after second booster injections were
used to isolate total IgGs by ammonium sulfate precipi-
tation. After dialysis against PBS, monospecific antibodies
were prepared by affinity chromatography using peptide
immobilized on Sulfonik-coupling gel (Pierce Biotechnol-
ogy, Inc.). Specificity was determined by ELISA assays
using the above peptide as positive control and unrelated
proteins as negative controls.REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION
(RT-PCR)
RT-PCR analysis of gene expression levels was carried
out as described24. Primer pairs used were the following:
cRunx2, 5′-GCA TTC CTC ATC CCA GTA TGA GA-3′ and
5′-GTA AAG GTG GCT GG(G/A) TAG TGC A-3′; HPRT,
5′-GC(A/G) TCG TGA TT(A/G) GCG ATG ATG A-3′ and
5′-GTC (A/G)AG GGC (A/G)TA TCC AAC AAC A-3′; Ihh,
5′-GCT CGC CTA CAA GCA GTT CAG-3′ and 5′-GAC TTG
ACG GAG CAG TGG ATG-3′; Type IX collagen, 5′-ATT
CTG GGT GCT CGT CAA AGA AC-3′ and 5′-AGC ACT
GAG AAG CCA TCA ACA CT-3′; Type X collagen, 5′-AAG
CAG GAG CAA ATC AAG CTC TC-3′ and 5′-GTC AGG
ACA TTG TAA GTG GGA TG-3′; Sox9, 5′-TAC CTA CGG
CAT CAG CAG CTC-3′ and 5′-TTG CCT TCA CGT GGC
TTT AAG-3′; MMP-13, 5′-CTT CGT GGA GAA ATG CTG
GTC TT-3′ and 5′-TCG CAG AAC TCT GCT TTC CTC
TA-3′; and cRunx2, 5′-CCC TCT CTG AAC TCT GCA CCA
AGT-3′and 5′-GGT AAA GGT GGC TGG ATA GTG CAT-3′.
The amplified products were sequenced to verify identity of
PCR products in each experiment.IN SITU HYBRIDIZATION AND NORTHERN HYBRIDIZATION
In situ hybridization was carried out with 35S-labeled
riboprobes as described in detail elsewhere26. 330 bp
cRunx2 fragment ( nucleotide 721-1050 of AF450085) was
amplified by PCR with cRunx2 PCR primers (5′-GCA TTC
CTC ATC CCA GTA TGA GA-3′ and 5′-GTAAAG GTG GCT
GG(G/A) TAG TGC A-3′), subcloned into pGEM-T vector
and used to generate cRunx2 riboprobe. The other cDNA
clones used were described previously14. For Northern
hybridization, isolated whole cellular RNAs27 were de-
natured by glyoxalation, electrophoresed on agarose gels,
transferred to Hybond-N membrane (Amersham Life Sci-
ence, Tokyo, Japan) by capillary blotting, and hybridized to
32P-labeled cRunx2 DNA probes.ResultsCLONING OF CHICK RUNX2
In the first set of studies, we cloned chick Runx2 and
compared its structural and functional characteristics to
those of its mammalian counterparts7–9. We prepared an
adaptor-ligated cDNA library using RNA from Day 16 chick
embryo cartilaginous tibias and used it as a template for
5′-RACE and 3′-RACE reactions, employing degenerative
primers based on human and mouse Runx2 sequences. A
single form of chick Runx2 (cRunx2) was obtained that is
highly homologous to the isofom of mouse Runx2 identified
as til-1 major isoform28 or major product of OSF229,30. The
predicted amino acid sequence of cRunx2 represented
very high homology to that of human Runx2 (NM 004348)
[Fig. 1(A)] and mouse Runx2 (AF010284) (not shown). On
the other hand, cRunx2 has a very short Q/A rich-domain
and lacks 30 amino acids in PST domain. This 30 amino
acid subdomain is encoded by a single exon in the human
gene (AF005498), suggesting the possibility that the main
form of cRunx2 expressed in the Day 16 chick tibia is a
splice variant.
To determine whether cRunx2 is differentially expressed
during chick chondrocyte maturation as occurs in mam-
malian systems, we carried out Northern blot and in situ
hybridization analyses. We found that cRunx2 transcripts
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trophic chick chondrocytes [Fig. 1(B), mature] than in
immature chondrocyte cultures [Fig. 1(B), immature]. Both
chondrocyte populations contained a major RNA band ofabout 6 kb [Fig. 1(B)] and a faint but discernable band
of larger size [Fig. 1(B)], indicating that cultured chondro-
cytes may actually express more than one Runx2 variant.
In situ hybridization was carried out on longitudinalFig. 1. Sequence analysis and expression patterns of cRunx2. (A) Alignment of predicted amino acid sequences of chick and human Runx2.
Identical residues are boxed. Q/A and Runt domains are underlined. (B) Northern blot analysis of cRunx2 gene expression in immature (lane
1) and hypertrophic (lane 2) chondrocytes in culture. (C–K) In situ hybridization analyses of gene expression patterns in Day 6 (C–F) and
Day 11 (G–K) chick embryo limb skeletal elements. Serial longitudinal sections were hybridized with 35S-labeled riboprobes encoding the
indicated genes. Phase micrograph showing day 6 cartilaginous ulna (u) and radius (r) is presented in (C). Bar, 150 m.
10 M. Iwamoto et al.: Runx2 regulation in chondrocytessections of chick embryo limbs at different stages of devel-
opment. cRunx2 transcripts were extremely abundant in
perichondrial tissues at early stages of limb skeletogenesis,
such as ulna and radius rudiments in Day 6 wing bud [Fig.
1(C),(D)]. Transcripts encoding the signaling protein Indian
hedgehog (Ihh) were present throughout the diaphyseal
portion of these rudiments [Fig. 19e)], indicating that the
chondrocytes were still developmentally young and had not
passed the prehypertrophic stage. Hybridization with sense
Runx2 riboprobe produced no signal demonstrating speci-
ficity of hybridization data [Fig. 1(F)]. Analysis of longi-
tudinal sections from older Day 11 limbs showed that
cRunx2 was expressed in a form of a gradient throughout
the growth plate of developing skeletal elements such as
tibia [Fig. 1(K)]. Hybridization signal was low in the epiphy-
seal region containing pre-articular chondrocytes and
immature chondrocytes and appeared to steadily increase
in proliferative and pre-hypertrophic zones in the meta-
physis [Fig. 1(K)]. Maximal cRunx2 expression was seen in
hypertrophic and post-hypertrophic cells and endochondral
bone cells in the diaphysis and in the intramembranous
bone collar [Fig. 1(K)]. As expected, these sites of intense
cRunx2 expression also showed intense osteopontin gene
expression [Fig. 1(J)], reflecting ongoing active terminal
chondrocyte maturation and osteogenesis. In situ hybrid-
ization analysis of companion serial sections of Day 11 tibia
confirmed the identity and boundaries of the various growth
plate zones. Abundant type II collagen transcripts were
present in every growth plate zone except in post-
hypertrophic zone [Fig. 1(G)]; Ihh RNAs were largely
restricted to pre-hypertrophic chondrocytes [Fig. 1(H)]; and
type X collagen transcripts were prominent in hypertrophic
chondrocytes [Fig. 1(I)].FUNCTIONAL ANALYSIS OF CRUNX2
To analyse the transcriptional activity of cRunx, we
constructed pSG5-based expression vectors encoding full
length cRunx2 or a truncated dominant negative (DN) form
which lacks the PST domain [Fig. 2(A)] and tested them in
transactivation assays. Vectors were transfected in chick
embryo immature sternal chondrocytes in culture along
with a luciferase reporter construct containing six copies
of osteoblast-specific Runx2-binding elements from the
osteocalcin gene promoter (6×OSE), and reporter activity
was measured 24 h later. When pSG5-cRunx2 and luci-
ferase reporter were co-transfected, reporter activity
increased in a dose-dependent manner [Fig. 2(B), samples
2–4] compared with reporter activity in control cells trans-
fected with empty pSG5 vector [Fig. 2(B), sample 1]. When
both pSG5-cRunx2 and pSG5-DN-Runx2 vectors were
co-transfected along with reporter construct, there was no
substantial increase in reporter activity [Fig. 2(B), samples
5–7]. The data indicate that cRunx2 has transcriptional
activity similar to that of its mammalian orthologues8 and
that DN-cRunx does have dominant negative activity.
To examine the biological functions of cRunx2, we
constructed RCAS retroviruses encoding cRunx2 or
DN-cRunx2. Viral particles were used to infect primary
populations of immature chick sternal chondrocytes and
determine effects of virally-driven over-expression of these
proteins on behavior and maturation of the cells in culture.
To establish that the retroviral constructs had indeed
elicited over-production of cRunx2 or DN-cRunx2, we
raised antibodies to cRunx2 and used them in Western blot
analyses. Antisera were produced in rabbits against a
synthetic peptide corresponding to the amino-terminalFig. 2. Structure and transactivation activities of cRunx2 and DN-cRunx2. (A) Schematic representation of cRunx2 and DN-cRunx2. Q/A,
Runt, NLS (nuclear localization signal) and PST domains are indicated. (B) Relative luciferase activity elicited after plasmid transfection in
second-passage immature chondrocyte cultures. Cultures received 0.5 g of Runx2 target gene reporter plasmid (p6×OSE2-Luc), 0.2 g of
control reference reporter plasmid (pRL-SV40), and indicated amounts of cRunx2 and/or DN-expression plasmid. To control for plasmid
concentration, cultures were transfected with appropriate amounts of insert-less pSG5 plasmid such as total amount of plasmids received
by each culture was 3.3 g. Relative luciferase activity was determined after 24 h from transfection as described8. Values are means of four
wells. Similar results were obtained in two independent experiments.
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bodies were characterized by ELISA and immunostaining
assays (Gentili et al., in preparation). Western analysis
showed that a strong band of 55 kDa was present in
nuclear extracts of cRunx2-virally infected chondrocyte
cultures [Fig. 3(A), lane 4] corresponding precisely to the
expected size of cRunx2. In nuclear extracts from cRunx2-
DN-virally infected chondrocyte cultures there was a strong
band of 29 kDa [Fig. 3(A), lane 3] which is the expected
size of truncated DN-cRunx2. Endogenous cRunx2
was barely detectable in control cultures by these means
[Fig. 3(A), lane 2], probably due to its very low expression.
Expression of cRunx2 and DN-cRunx2 gave very similar
effects to these of mouse Runx2 and DN-mouse Runx2
as we have reported previously8,9. Control cultures and
cultures infected with cRunx-2 or DN-cRunx2 viruses all
expressed the chondrocyte master regulator Sox9 and
chondrocyte-characteristic type IX collagen, indicating that
the cells had remained differentiated and functional [Fig.
3(B)]. Compared to control cells, cRunx2 over-expression
led to a clear increase in expression of such maturation
markers as type X collagen and metalloprotease-13 (MMP-
13), while DN-cRunx2 inhibited expression of both of them
markedly [Fig. 3(B)]. Interestingly, DN-cRunx2 inhibited
expression of the prehypertrophic marker Ihh, while
cRunx2 inhibited expression of the immature chondrocyte
marker tenascin-C26 [Fig. 3(B)], indicating that cRunx2
function regulates chondrocyte behavior and function at
multiple stages from the least immature to the fully hyper-
trophic stage. Expression of housekeeping HPRT was
equal among the three cell populations, reiterating that the
cells had remained vital and their different phenotypes were
not due to non-specific toxic effects [Fig. 3(B)].MODULATION OF CRUNX2 ACTION BY RA
To determine whether retinoid signaling affects cRunx2
action, chondrocyte cultures over-expressing cRunx 2 orDN-cRunx2 and companion uninfected cultures were
treated with physiologic doses (10 nM) of all-trans-retinoic
acid (RA) for 5 days and were examined by microscopic,
biochemical and histochemical means. RA treatment of
uninfected cultures caused cell flattening and loss of peri-
cellular refractile matrix [Fig. 4(A), panel 4]14 compared to
their untreated counterpart [Fig. 4(A), panel 1]. Interest-
ingly, RA treatment of cRunx2 over-expressing cells failed
to cause flattening and the cells remained round to poly-
gonal in shape and highly refractile [Fig. 4(A), panel 5].
In DN-cRunx2 over-expressing RA-treated cultures the
chondrocytes still displayed overcrowding, small average
cell size, and paucity of pericellular refractile matrix
[Fig. 4(A), panel 6].
Histochemical analyses were used to monitor the effects
of cRunx2 or DN-cRunx2 over-expression on pericellular
proteoglycan content by alcian blue staining, alkaline phos-
phatase (APase) activity by in situ enzymatic staining, and
matrix mineralization by alizarin red staining. These analy-
ses showed that cRunx2 over-expression increased proteo-
glycan content [Fig. 4(B), panel 2] and strongly induced
both APase activity [Fig. 4(C), panel 2] and mineralization
[Fig. 4(D), panel 2] compared to control (panels 1 of
Fig. 4(B)–(D)]. Instead, DN-cRunx2 decreased all these
parameters [panels 3 of Fig. 4(B)–(D)].
As expected on the basis of our previous reports13–15,
RA treatment of uninfected cultures reduced proteoglycan
content [Fig. 4(B), panel 4; see Fig. 4(A), panel 4 also] and
strongly enhanced APase [Fig. 4(C), panel 4] and mineral-
ization [Fig. 4(D), panel 4]. Even stronger enhancement
of APase activity and mineralization occurred in Runx2-
overexpressing RA-treated cultures [Fig. 4(C), panel 5 and
4(D), panel 5] whereas DN-cRunx2 over-expression pre-
vented induction of these parameters by RA [Fig. 4(C),
panel 6 and 4(D), panel 6]. However, RA treatment
decreased proteoglycan content regardless of over-
expression of cRunx2 or DN-cRunx2 [Fig. 4(C), panels 5
and 6]. Direct biochemical measurements of proteoglycan
content and APase activity confirmed the above histo-
chemical observations [Fig. 5(A),(B)]. Together, the data
indicate that cRunx2 and retinoid signaling co-operate to
induce APase activity and matrix mineralization in maturing
chondrocytes, whereas retinoid signaling regulates peri-
cellular proteoglycan content independent of presence or
inactivation of cRunx2 function.MODULATION OF CRUNX2 ACTION BY PTHRP
Similar microscopic and histochemical analyses were
carried out to determine the possible effects of PTHrP on
cRunx2 roles in chondrocytes. Treatment of uninfected
cultures with 100 nM PTHrP left the cells round in shape
and highly refractile [Fig. 4(A), panel 7], increased their
proteoglycan content moderately [Fig. 4(B), panel 7],
and decreased both APase activity and mineral content
[Fig. 4(C), panel 7 and (D), panel 7], in line with previous
studies17,18. When cRunx2 over-expressing cultures were
treated with PTHrP, the cells retained a round shape [Fig.
4(A), panel 8] and high proteoglycan content [Fig. 4(B),
panel 8], but had less APase activity [Fig. 4C, panel 8] and
no matrix mineralization [Fig. 4(D), panel 8] compared to
untreated cRunx2 over-expressing cultures (panels 2 of
Fig. 4(B)–(D)). PTHrP treatment of DN-cRunx2 over-
expressing cultures did not produce further significant
changes in cell morphology [Fig. 4(A), panel 9] and activi-
ties [panels 9 of Fig. 4(B)–(D)) compared with untreatedFig. 3. Molecular analyses of cRunx2 and DN-cRunx2 effects on
chondrocytes. (A) Nuclear extracts from second-passage chondro-
cyte cultures infected with control (lane 2), cRunx2 (lane 3) or
DN-cRunx2 (lane 4) viruses were processed for immunoblot analy-
sis using monospecific rabbit anti-cRunx2 peptide antibodies. Lane
1 contains molecular weight markers. (B) RT-PCR analysis of gene
expression patterns. Total RNAs isolated from secondary cultures
infected with control, cRunx2 and DN-cRunx2 viruses were ana-
lysed for expression levels of the following genes: Sox9; type IX
collagen (Type IX); tenascin-C (TN); Indian hedgehog (Ihh);
metalloprotease-13 (MMP 13); type X collagen (Type X); and
HPRT.
12 M. Iwamoto et al.: Runx2 regulation in chondrocytesDN-cRunx2 over-expressing cultures [panels 3 of Fig.
4(B)–(D)]. Biochemical assays confirmed these histo-
chemical observations [Fig. 5(A),(B)]. The data indicate
that PTHrP can counteract the beneficial effects of cRunx2,
APase activity and mineralization, but does not appear
to further reduce phenotypic expression in DN-cRunx2
over-expressing chondrocytes.EFFECTS OF RA AND PTHRP ON CRUNX2 EXPRESSION
In a final set of experiments, we asked whether RA and
PTHrP affect cRunx2 gene expression in chondrocytes.
Total RNAs isolated from chondrocyte cultures treated with
RA or PTHrP for 4 days were analysed by RT-PCR. After 22cycles of amplification, we obtained a faint cRunx2 band in
control sample, a much stronger band in RA-treated
sample, and no band in PTHrP-treated sample [Fig. 6(A),
22 cycles]. When 26 cycles of amplification were carried
out, band intensities increased proportionally, but quantita-
tive differences among the three cultures remained the
same [Fig. 6(A), 26 cycles].Discussion
Our data demonstrate that Runx2 expression and func-
tion in chondrocytes are affected by such potent effectors ofFig. 5. Histograms showing proteoglycan and APase levels. Cul-
tures similar to those in Fig. 4 were processed for biochemical
quantification of (A) proteoglycan content and (B) APase activity
associated with the cell layers. Data were normalized to DNA
content. Values were means plus S.D. of three wells. Two indepen-
dent experiments produced similar results.Fig. 4. Morphological and histocheminal analyses of chondrocyte
cultures. (A) Phase contrast micrographs of second-passage
chondrocyte cultures infected with (panel 1) control, (panel 2)
cRunx2 or (panel 3) DN-cRunx2 viruses. Companion cultures were
treated with 10 nM RA (panels 4–6) or 100 nM PTHrP (panels 7–9)
starting 2 days after passage and continued for 5 days. All
micrographs were taken simultaneously at the end of treatment.
Bar, 50 m. (B), (C) Cultures identical to those in (A) were
processed for detection of cell layer-associated proteoglycan (B)
and APase (C) on Day 7. Note the increase in proteoglycan
staining in cRunx2-over-expressing cultures (panel 2) and the
decrease in proteoglycan content following RA treatment (panels
4–6). Note also that both cRunx2 (panel 2) and RA (panel 4)
greatly stimulate APase activity, particularly together (panel 5). (D)
The similar cultures were grown for an additional 7 days in the
presence of 1 mM -glycerophosphate serving as a phosphate
donor and were then stained with alizarin red. (panels 1–3)
cultures infected with control, cRunx2 or DN-cRunx2 viruses;
(panels 4–6) companion cultures treated with 10 nM RA for
12 days; (panels 7–9), companion cultures treated with 100 nM
PTHrP for 12 days. Note that both cRunx2 (panel 2) and RA
(panel 4) induce mineralization, and that PTHrP completely blocks
cRunx2-induced mineralization (panel 8).
Osteoarthritis and Cartilage, Vol. 11, No. 1 13chondrogenesis and osteogenesis as PTHrP and retinoid
signaling. The data reiterate the importance of Runx2 in
skeletogenesis and point to interesting modes of regulation
of its action and roles in skeletal cells.CHICK RUNX2
In mammalian skeletal cells, two major isoforms of
Runx2 are expressed and are translated from different
mRNAs4,30. These isoforms are expressed in bone and
cartilage and have similar stimulatory effects on osteoblast
differentiation and chondrocyte maturation7. However, they
show some differences in their ability to transactivate target
reporter constructs31, suggesting that they have some
unique but still undefined functions in skeletal develop-
ment. Our Northern blot data show that chick chondrocytes
contain a major cRunx2 transcript of about 6 kb and a
fainter, larger species, indicating that chondrocytes, and in
particular cultured chondrocytes, express mainly one
Runx2 species. Comparative sequence analysis reported
here indicates that for the most part chick Runx2 is highlyhomologous to human Runx2, but contains a much shorter
glutamine-alanine (QA) domain. This is consistent with the
result recently reported by Sticker et al.32 The QA domain
was previously found to serve as a second activation
domain of Runx2, as determined by OSE reporter
assays29. When the domain was completely absent, trans-
activation activity of QA-lacking mammalian Runx2 was
greatly decreased. However, when 15 out of the total 18
alanine residues were absent, transactivation function was
not affected. This observation is consistent with our finding
that although chick Runx2 contains only two alanine resi-
dues in QA domain, it does have the ability to transactivate
reporter OSE-containing reporter constructs and to affect
chondrocyte function and phenotype. In addition, the very
short QA domain is compatible with the dominant-negative
activity of our DN-cRunx2 construct, indicating that the
shortened domain still allows the truncated form to interact
with appropriate nuclear factors and interfere with function.REGULATION OF RUNX2 EXPRESSION
Given the critical role of Runx2 in osteogenesis, it is not
surprising that many studies have focused on its regulation
in osteoprogenitor cells and osteoblasts. For example,
members of the bone morphogenetic protein family and
transforming growth factor b-1 have been found to act as
inducers or stimulators positive factors of Runx2 gene
expression33, while tumor necrosis factor alpha34, fibro-
blast growth factors35 and glucocorticoids36 exert negative
influences. There is, however, much less information on the
regulation of Runx2 gene expression in chondrocytes,
though the importance of Runx2 in cartilage development
and maturation is indisputable. Our focusing on the roles of
retinoid signaling and PTHrP in Runx2 expression as well
as function stems from the fact that these regulatory
mechanisms are so critical to cartilage development. RA,
the most potent and critical retinoid in biological systems, is
a potent stimulator of chondrocyte maturation, as indicated
by increases in APase activity, type X collagen gene
expression and matrix mineralization13,14. Pharmacological
interference with endogenous retinoid signaling blocks long
bone development, chondrocyte maturation and osteo-
genesis in developing chick embryos22. In contrast, PTH/
PTHrP is a known negative regulator of chondrocyte
maturation17,18 and endochondral ossification19,20. Our
data on the effects of RA and PTHrP on cRunx2 gene
expression are quite consistent with the roles of these
molecules in chondrocytes and cartilage development. The
clear stimulation of cRunx2 expression by RA and the
inhibition by PTHrP indicate that transcriptional regulation
of Runx2 gene is likely to represent one mechanism by
which RA and PTHrP exert their roles. A positive role of
retinoid signaling in Runx2 gene expression was also
described in a recent study37.MODULATION OF RUNX2 FUNCTION
Although RA and PTHrP influence Runx2 gene expres-
sion, these changes do not account for all the effects of
these molecules on chondrocyte behavior and function. RA
affects several parameters in chondrocytes. It stimulates
proliferation and maturation, inhibits proteoglycan syn-
thesis and accumulation, and induces a flattened and
elongated cell shape13–15,38. The results of our study
indicate that the stimulation of chondrocyte maturation isFig. 6. (A) Effects of RA and PTHrP on cRunx2 gene expression.
Chondrocyte cultures were treated with 10 nM RA or 100 nM
PTHrP for 4 days and total RNA isolated on day 7 of culture were
subjected to RT-PCR amplification for 22 and 26 cycles, followed
by separation of PRC products by gel electrophoresis. Note the
presence of a single major cRunx2 PCR product exhibiting the
expected size of bp. The DNA markers shown were: 1353; 1078;
872; and 603 bp long. (B) A model integrating Runx2 with Ihh,
PTHrP and retinoid signaling and postulated to regulate chondro-
cyte behavior and maturation in the growth plate in developing
skeletal elements. Arrows indicate positive effects and truncated
bars indicate negative effects. A question mark represents a
possible, but not certified stimulatory effect. See text for details.
14 M. Iwamoto et al.: Runx2 regulation in chondrocytesmediated by and dependent on Runx2. Indeed, when
chondrocytes over-express cRunx2 and are also treated
with RA, expression of maturation parameters is boosted
over that seen in cells over-expressing cRunx2 or treated
with RA only. In addition, RA is unable to induce character-
istics of maturation in DN-cRunx2 over-expressing
chondrocytes. On the other hand, the inhibition of proteo-
glycan content and cell flattening induced by RA treatment
are not seen in chondrocytes over-expressing cRunx2 only,
and similar effects are even elicited in chondrocytes over-
expressing DN-cRunx2. It is clear, then, that some of the
effects of retinoid signaling in chondrocytes may be dis-
sociated from, and possibly are independent of, cRunx2.
The inhibition of cRunx expression by PTHrP is in
keeping with the well established negative roles of this
cytokine as well as PTH on chondrocyte maturation and
hypertrophy17,18. The inhibitory potency of PTHrP is
reiterated by our finding that PTHrP blocks the pro-
maturation effects of Runx2 over-expression in chondro-
cytes (Figs 4 and 5). In these cells, PTHrP completely
blocked matrix calcification and decreased APase activity
markedly. The mechanisms of PTHrP inhibition of cRunx2
expression and function are not clear at the moment.
PTHrP may induce transcription factors that negatively
regulate Runx2 expression and transactivation activity39.
PTHrP may also maintain expression of immature traits in
chondrocytes which interfere and block the pro-maturation
activity of Runx2. Whatever the mechanisms, it is apparent
that as seen with retinoid signaling, some chondrocyte
phenotypic traits are strictly dependent on Runx2 action
and thus completely affected by the anti-maturation activity
of PTHrP (such as matrix mineralization), whereas other
traits may be controlled by multiple mechanisms including
Runx2.A MODEL
As previous studies and the present data indicate,
Runx2 is required for expression of Ihh8,40 and is able to
further stimulate Ihh expression in chondrocytes. Findings
have also indicated that PTHrP expression is induced by
Ihh41 and that PTHrP inhibits Runx2 expression and func-
tion. It is clear that complex regulatory loops exist in
developing skeletal elements to control spatially and tem-
porally the progression of chondrocyte maturation in the
growth plate and co-ordinate it with events in surrounding
tissues. We propose the following model which integrates
Runx2 with Ihh, PTHrP and retinoid signaling [Fig. 6(B)].
Developing cartilaginous skeletal elements would initiate
expression of Runx2 (by as yet unknown triggers). PTHrp,
induced by IHH, would operate in the upper zones of
growth plates to maintain chondrocytes in a proliferative
state. Retinoid signaling, probably deriving from perichon-
drial tissues22 would further boost Runx2 gene expression;
this would allow chondrocytes to escape the inhibitory influ-
ences of PTHrP and advance toward maturation. Increased
Runx2 expression and retinoid signaling would together
induce terminal maturation traits (APase, mineralization,
decreased proteoglycan synthesis, etc), thus permitting nor-
mal cartilage-to-bone transition and normal progression of
endochondral ossification and skeletal growth.Acknowledgments
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